Policy Point: Pharmac should not be criticised simply for being selective and slow about the medicines it funds

Dr Bryce Wilkinson
Policy Point
3 August, 2023

Pharmac is often criticised for not funding enough new medicines and for being too slow to determine which ones it will fund. However, being slow and focused is not proof of being too slow or too focused. Newish evidence from Germany reinforces this point.

Stay in the loop: Subscribe to updates